HURTIGT OPLØSENDE FORMULERING AF CINACALCET-HCL

The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a calcium receptor-active compound and at least one pharmaceutically acceptable excipient, wherein the composition has a controlled dissolution profile. The present invention further relate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lin, Hung-Ren H, Lawrence, Glen Cary, Ju, Tzuchi R, ÁLVAREZ, Francisco J
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Lin, Hung-Ren H
Lawrence, Glen Cary
Ju, Tzuchi R
ÁLVAREZ, Francisco J
description The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a calcium receptor-active compound and at least one pharmaceutically acceptable excipient, wherein the composition has a controlled dissolution profile. The present invention further relates to a method of manufacturing the pharmaceutical composition, as well as a method of treating a disease using the pharmaceutical composition.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK3395339TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK3395339TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK3395339TT33</originalsourceid><addsrcrecordid>eNrjZDDwCA0K8XQPUfAP8Dk8I9jVz8VVwc0_yDfUxzXI089dwdFNwdnTz9HZ0cfZNUTXw9mHh4E1LTGnOJUXSnMzKLq5hjh76KYW5MenFhckJqfmpZbEu3gbG1uaAnFIiLExMWoAoRYnhQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HURTIGT OPLØSENDE FORMULERING AF CINACALCET-HCL</title><source>esp@cenet</source><creator>Lin, Hung-Ren H ; Lawrence, Glen Cary ; Ju, Tzuchi R ; ÁLVAREZ, Francisco J</creator><creatorcontrib>Lin, Hung-Ren H ; Lawrence, Glen Cary ; Ju, Tzuchi R ; ÁLVAREZ, Francisco J</creatorcontrib><description>The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a calcium receptor-active compound and at least one pharmaceutically acceptable excipient, wherein the composition has a controlled dissolution profile. The present invention further relates to a method of manufacturing the pharmaceutical composition, as well as a method of treating a disease using the pharmaceutical composition.</description><language>dan</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190722&amp;DB=EPODOC&amp;CC=DK&amp;NR=3395339T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190722&amp;DB=EPODOC&amp;CC=DK&amp;NR=3395339T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Lin, Hung-Ren H</creatorcontrib><creatorcontrib>Lawrence, Glen Cary</creatorcontrib><creatorcontrib>Ju, Tzuchi R</creatorcontrib><creatorcontrib>ÁLVAREZ, Francisco J</creatorcontrib><title>HURTIGT OPLØSENDE FORMULERING AF CINACALCET-HCL</title><description>The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a calcium receptor-active compound and at least one pharmaceutically acceptable excipient, wherein the composition has a controlled dissolution profile. The present invention further relates to a method of manufacturing the pharmaceutical composition, as well as a method of treating a disease using the pharmaceutical composition.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDwCA0K8XQPUfAP8Dk8I9jVz8VVwc0_yDfUxzXI089dwdFNwdnTz9HZ0cfZNUTXw9mHh4E1LTGnOJUXSnMzKLq5hjh76KYW5MenFhckJqfmpZbEu3gbG1uaAnFIiLExMWoAoRYnhQ</recordid><startdate>20190722</startdate><enddate>20190722</enddate><creator>Lin, Hung-Ren H</creator><creator>Lawrence, Glen Cary</creator><creator>Ju, Tzuchi R</creator><creator>ÁLVAREZ, Francisco J</creator><scope>EVB</scope></search><sort><creationdate>20190722</creationdate><title>HURTIGT OPLØSENDE FORMULERING AF CINACALCET-HCL</title><author>Lin, Hung-Ren H ; Lawrence, Glen Cary ; Ju, Tzuchi R ; ÁLVAREZ, Francisco J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK3395339TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Lin, Hung-Ren H</creatorcontrib><creatorcontrib>Lawrence, Glen Cary</creatorcontrib><creatorcontrib>Ju, Tzuchi R</creatorcontrib><creatorcontrib>ÁLVAREZ, Francisco J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Lin, Hung-Ren H</au><au>Lawrence, Glen Cary</au><au>Ju, Tzuchi R</au><au>ÁLVAREZ, Francisco J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HURTIGT OPLØSENDE FORMULERING AF CINACALCET-HCL</title><date>2019-07-22</date><risdate>2019</risdate><abstract>The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a calcium receptor-active compound and at least one pharmaceutically acceptable excipient, wherein the composition has a controlled dissolution profile. The present invention further relates to a method of manufacturing the pharmaceutical composition, as well as a method of treating a disease using the pharmaceutical composition.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK3395339TT3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title HURTIGT OPLØSENDE FORMULERING AF CINACALCET-HCL
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T02%3A54%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Lin,%20Hung-Ren%20H&rft.date=2019-07-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK3395339TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true